As health systems continue to balance clinical needs, operational complexity, drug shortages, and financial pressures, 505(b)(2) therapeutics may offer new opportunities to support pharmacy and patient care. This session will explore how pharmacy leaders can assess the value of these therapies, consider their role within existing treatment pathways, and address practical implementation considerations across health-system settings.